Validation of immunoassay-based tools for the comprehensive quantification of Aβ40 and Aβ42 peptides in plasma

Manuscript Number: 

16-0325R2

Author(s): 
Jesús Canudas, Diego Casabona, Noelia Fandos, Daniel Insua, Ana-María Lacosta, María Montañés, Pedro Pesini, Virginia Pérez-Grijalba, Manuel Sarasa

Disclosures

Jesús Canudas

  • Sponsors:
    Researcher

Diego Casabona

  • Sponsors:
    Researcher

Noelia Fandos

  • Nothing to Disclose

Daniel Insua

  • Sponsors:
    Researcher

Ana-María Lacosta

  • Sponsors:
    Researcher

María Montañés

  • Sponsors:
    Researcher

Virginia Pérez-Grijalba

  • Nothing to Disclose

Pedro Pesini

  • Sponsors:
    Director, R&D

Manuel Sarasa

  • Equity:
    Scientific founder (2004) and one of the current shareholders of Araclon Biotech Ltd.
    Sponsors:
    President, CEO and CSO of Araclon Biotech Ltd.
    Patents/Royalties
    Inventor of several patents related to Alzheimer's disease diagnosis and treatment.